The potential role of lactoferrin and derivatives in the management of infectious and inflammatory complications of hematology patients receiving a hematopoietic stem cell transplantation
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Human lactoferrin is a natural defense protein belonging to the innate immune system present in several body fluids and secretions, as well as in the secondary granules of polymorphonuclear neutrophils. Lactoferrin and its derivatives have pleiotropic functions including broad‐spectrum anti‐microbial activity, anti‐tumor activity, regulation of cell growth and differentiation, and modulation of inflammatory as well as humoral and cellular immune responses. This is the reason why much research has addressed the potential therapeutic activity of these molecules in different clinical settings, especially regarding infectious diseases and uncontrolled inflammatory conditions. In patients with hematological malignancies treated with a hematopoietic stem cell transplantation (HSCT), morbidity and mortality due to infections and uncontrolled inflammation remains high, despite many advances in supportive care. These life‐threatening complications are a result of the damage caused by the conditioning regimens to the mucosal barrier, and the innate and adaptive, humoral, and cellular immune defenses. These complications necessitate the continued exploration of new treatment modalities. Systemic and probably local levels of lactoferrin are decreased following HSCT. Therefore, the use of lactoferrin, or short peptide derivatives that retain the cationic N‐terminal moiety that is essential for the anti‐microbial and anti‐inflammatory activity, may prove to be a promising versatile class of agents for managing the complications that arise from HSCT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lactoferrin: Multifunctional roles of lactoferrin: a critical overview
Ward, P. P., Paz, E., & Conneely, O. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5369-8 · Cited by 443
Bellamy, W., Wakabayashi, H., Takase, M., Kawase, K., Shimamura, S., & Tomita, M. (1993) · Medical Microbiology and Immunology · doi:10.1007/bf00189377 · Cited by 219
Elucidation of the antistaphylococcal action of lactoferrin and lysozyme
Leitch, E. C., & Willcox, M. D. P. (1999) · Journal of Medical Microbiology · doi:10.1099/00222615-48-9-867 · Cited by 128 · cited 5×
“Because PMNs in chronic myeloid leukemia were shown to Abbreviations: CpG-DNA, CpG motifs of bacterial DNA; GVHD, graft-versus-host disease; HSCT, hematopoietic stem cell transplantation; HSPG, heparan sulfate proteoglycan; HLF1-11, human lactoferrin 1-11; IEC, intestinal epithelial cell; IL, interleukin; Lfcin, lacto…”
BackgroundInfluentialFischer, R., Debbabi, H., Dubarry, M., Boyaka, P., & Tomé, D. (2006) · Biochemistry and Cell Biology · doi:10.1139/o06-058 · Cited by 104 · cited 2×
“, by increasing IL-10 and decreasing IL-12 and IL-18 secretion, which would be bene¢cial during the e¡ector phase of GVHD (28, 33, 34).”
Background
Cited by
Fischer, R., Debbabi, H., Dubarry, M., Boyaka, P., & Tomé, D. (2006) · Biochemistry and Cell Biology · doi:10.1139/o06-058 · Cited by 104
Discovery and development of a synthetic peptide derived from lactoferrin for clinical use
Brouwer, C. P. J. M., Rahman, M., & Welling, M. M. (2011) · Peptides · doi:10.1016/j.peptides.2011.07.017 · Cited by 90
“Also, lactoferrin was used as a prophylactic as a novel therapeutic approach for prophylaxis of GvHD in patients undergoing allogeneic HSCT [2,132].”
MethodRoles of the intestinal microbiota and microbial metabolites in acute GVHD
Lin, D., Hu, B., Li, P., Zhao, Y., Xu, Y., & Wu, D. (2021) · Experimental Hematology & Oncology · doi:10.1186/s40164-021-00240-3 · Cited by 71
Applications of gut microbiota in patients with hematopoietic stem-cell transplantation
Yu, J., Sun, H., Cao, W., Han, L., Song, Y., Wan, D., & Jiang, Z. (2020) · Experimental Hematology & Oncology · doi:10.1186/s40164-020-00194-y · Cited by 25
Metadata
- Authors
- Van Der Velden, W. J. F. M., Blijlevens, N. M. A., & Donnelly, J. P.
- Venue
- Transplant Infectious Disease
- Publisher
- Wiley
- Published
- 2007-07
- Volume
- 10
- Issue
- 2
- Pages
- 80-89
- ISSN
- 1398-2273 (ISSN-L)
- 1399-3062
- OpenAlex
- W2101792952
- Cited by
- 18
- References
- 4
- FWCI
- 0.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The potential role of lactoferrin and derivatives in the management of infectious and inflammatory complications of hematology patients receiving a hematopoietic stem cell transplantation. https://app.cochat.ai/papers/10.1111/j.1399-3062.2007.00260.x
- The paper
- Van Der Velden, W. J. F. M., Blijlevens, N. M. A., & Donnelly, J. P. (2008). The potential role of lactoferrin and derivatives in the management of infectious and inflammatory complications of hematology patients receiving a hematopoietic stem cell transplantation. Transplant Infectious Disease. https://doi.org/10.1111/j.1399-3062.2007.00260.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.